omega-aminoenantic acid has been researched along with Blood Clot in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, H; Murayama, N; Sasaki, T; Sugimoto, K; Takada, K; Yamamoto, K; Yamazaki, H; Yoshimoto, N | 1 |
| Gils, A; Vercauteren, E | 1 |
2 other study(ies) available for omega-aminoenantic acid and Blood Clot
| Article | Year |
|---|---|
Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis.
Topics: Administration, Intravenous; Administration, Oral; Amino Acids; Animals; Carboxypeptidase B2; Fibrinolysis; Fibrinolytic Agents; Humans; Lysine; Male; Rats; Sulfur Compounds; Thromboplastin; Thrombosis | 2012 |
Is there any need for a TAFI(a) inhibitor as thrombolytic drug?
Topics: Amino Acids; Animals; Carboxypeptidase B2; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Thrombosis | 2012 |